Physician

Vidya Kora, MD

According to 2025 Medicare claims, Vidya Kora, MD (NPI: 1023075777) practices internal medicine in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is FRANCISCAN PHYSICIAN NETWORK (NPI: 1225327984; TIN: 611630276) and primary practice location at 46360-7310. Kora is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), participating under the MSSP model.

Kora's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 583 traditional Medicare patients, billed 3,997 HCPCS/CPT codes, and received $213,318 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 23,783 prescription claims across 1,107 beneficiaries totaling $1,913,858 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,127 claims. Open Payments data shows 17 records totaling $986. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $321,349 to $213,318. In contrast, Part D prescription costs have risen steadily, from $1,370,388 to $1,913,858. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $97,997 and ending at $100,103.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	985	8,139	$321,349
2016	980	7,685	$329,128
2017	1,052	8,280	$340,928
2018	1,026	8,004	$323,589
2019	845	9,225	$246,598
2020	775	7,574	$288,105
2021	729	5,340	$239,264
2022	697	5,122	$232,037
2023	609	4,036	$234,198
2024	583	3,997	$213,318

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	922	22,578	$1,370,388
2016	924	21,197	$1,454,490
2017	956	19,852	$1,433,594
2018	958	20,967	$1,666,066
2019	927	19,851	$1,710,695
2020	908	20,118	$1,823,362
2021	981	21,105	$1,978,547
2022	1,044	22,428	$2,253,664
2023	1,119	22,508	$2,400,781
2024	1,107	23,783	$1,913,858

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	659	2,149	$92,040
2016	676	2,030	$63,387
2017	626	2,052	$50,933
2018	630	2,041	$50,862
2019	569	1,995	$68,323
2020	535	1,780	$61,526
2021	551	1,707	$56,512
2022	428	1,531	$58,993
2023	345	1,449	$82,038
2024	340	1,127	$72,267

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	284	284	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	335	596	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	269	432	$53
90673	Influenza vaccine, trivalent derived from recombinant dna	141	141	$42
G0008	Administration of influenza virus vaccine	150	154	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	162	6,928	$226,052
Eliquis	Apixaban	184	9,460	$185,547
Januvia	Sitagliptin Phosphate	106	6,431	$120,056
Xarelto	Rivaroxaban	92	5,013	$92,283
Breo Ellipta	Fluticasone/Vilanterol	190	6,898	$90,698

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	19	80	$28,303
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	27	173	$11,541
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	12	$10,227
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	46	$3,063
A7032	Cushion for use on nasal mask interface, replacement only, each	N	11	26	$2,144

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$986	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vidya Kora, MD?

Tedicare shows public-source Medicare data for Vidya Kora, MD (NPI 1023075777), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vidya Kora, MD have ACO affiliation data?

Vidya Kora, MD is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550).

What billing organization is linked to Vidya Kora, MD?

Vidya Kora, MD is linked to FRANCISCAN PHYSICIAN NETWORK (billing NPI 1225327984) in the available physician profile data.

Does Vidya Kora, MD have Open Payments data?

Vidya Kora, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.